Endocrine System Diseases  >>  Growtropin-II (somatropin biosimilar)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Growtropin-II (somatropin biosimilar) / Dong-A
NCT01786902: Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

Completed
3
70
NA
DA-3002, Recombinant Human Growth Hormone
Dong-A ST Co., Ltd.
Idiopathic Short Stature
04/14
04/14
NCT01813630: A Clinical Study to Assess the Efficacy and Safety of DA-3002

Completed
3
58
RoW
DA-3002, Genotropin®
Dong-A ST Co., Ltd.
Turner's Syndrome
05/18
05/18

Download Options